Advertisement
Hoth Therapeutics Partners Altasciences For Study On HT-KIT Cancer Treatment
(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday that it has completed bioanalytical method development under its prior agreement with Altasciences.
The company now plans to further engage Altasciences to perform a key study of mouse blood and plasma analysis from samples collected in Hoth's sponsored scientific research conducted at NC State University.
The blood and plasma samples collected are part of a dose response study in a humanized mouse model.
The upcoming study will use the newly validated bioanalytical method developed at Altasciences to test the amount of HT-KIT from the dose response study and help determine how long HT-KIT remains in the blood stream post dosing.
read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews
|
vor 794 Tagen
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.
RTTNews
|
vor 1050 Tagen
Hoth Therapeutics Partners Altasciences For Manufacturing HT-TBI For Traumatic Brain Injury/Stroke
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Tuesday that it has signed an agreement with Altasciences, a fully integrated early phase CRO/CDMO, to develop and manufacture the HT-TBI drug product formulation.
RTTNews
|
vor 1150 Tagen
Soft Start Expected For Indonesia Stock Market
The Indonesia stock market turned lower again on Thursday, one day after ending the two-day slide in which it had fallen almost 30 points or 0.4 percent. The Jakarta Composite Index now sits just above the 8,370-point plateau and the losses may accelerate on Friday.
RTTNews
|
vor 1Std 18 Minuten
Hong Kong Shares Tipped To Open In The Red On Friday
The Hong Kong stock market has moved higher in four straight sessions, advancing almost 825 points or 3.5 percent along the way. The Hang Seng Index now rests just above the 27,070-point plateau although profit taking is expected on Friday.
RTTNews
|
vor 1Std 33 Minuten
Japanese Market Sharply Lower
Reversing the gains in the previous two sessions, the Japanese market is sharply lower on Friday, following the broadly negative cues from Wall Street overnight. The Nikkei 225 is falling below the 50,500 level, with weakness across most sectors led by index heavyweights and technology stocks.
RTTNews
|
vor 1Std 33 Minuten
China Shares May Open Under Water On Friday
The China stock market on Thursday ended the two-day slide in which it had fallen almost 20 points or 0.5 percent. The Shanghai Composite Index now sits just beneath the 4,030-point plateau although it may see renewed consolidation on Friday.
RTTNews
|
vor 1Std 48 Minuten
Australian Market Sharply Lower
The Australian stock market is trading sharply lower on Friday, extending the losses in the previous three sessions, following the broadly negative cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling well below the 8,650 level, with weakness across all sectors led by mining and technology stocks.
RTTNews
|
vor 2Std 0 Minuten
